COVID-19 and healthcare workers: A systematic review and meta-analysis.
COVID-19
Healthcare workers
Infectious disease transmission
Meta-analysis
Occupational health
SARS-CoV2
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
11
11
2020
revised:
05
01
2021
accepted:
06
01
2021
pubmed:
15
1
2021
medline:
12
5
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has focused attention on the challenges and risks faced by frontline healthcare workers (HCW). This study aimed to describe the clinical outcomes and risk factors for SARS-CoV-2 infection in HCW. Three databases were surveyed and 328 articles were identified. Of these, 225 articles did not meet inclusion criteria; therefore, 97 full-text article were reviewed. Finally, after further revision, 30 articles were included in the systematic review and 28 were used for meta-analysis. Twenty-eight studies were identified involving 119,883 patients. The mean age of the patients was 38.37 years (95% CI 36.72-40.03) and males comprised 21.4% (95% CI 12.4-34.2) of the population of HCW. The percentage of HCW who tested positive for COVID-19 was 51.7% (95% CI 34.7-68.2). The total prevalence of comorbidities in seven studies was 18.4% (95% CI 15.5-21.7). The most prevalent symptoms were fever 27.5% (95% CI 17.6-40.3) and cough 26.1% (95% CI 18.1-36). The prevalence of hospitalisation was 15.1% (95% CI 5.6-35) in 13 studies and of death was 1.5% (95% CI 0.5-3.9) in 12 studies. Comparisons of HCW with and without infection showed an increased relative risk for COVID-19 related to personal protective equipment, workplace setting, profession, exposure, contacts, and testing. A significant number of HCW were reported to be infected with COVID-19 during the first 6 months of the COVID-19 pandemic, with a prevalence of hospitalisation of 15.1% and mortality of 1.5%. Further data are needed to track the continued risks in HCW as the pandemic evolves and health systems adapt.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic has focused attention on the challenges and risks faced by frontline healthcare workers (HCW). This study aimed to describe the clinical outcomes and risk factors for SARS-CoV-2 infection in HCW.
METHODS
METHODS
Three databases were surveyed and 328 articles were identified. Of these, 225 articles did not meet inclusion criteria; therefore, 97 full-text article were reviewed. Finally, after further revision, 30 articles were included in the systematic review and 28 were used for meta-analysis.
RESULTS
RESULTS
Twenty-eight studies were identified involving 119,883 patients. The mean age of the patients was 38.37 years (95% CI 36.72-40.03) and males comprised 21.4% (95% CI 12.4-34.2) of the population of HCW. The percentage of HCW who tested positive for COVID-19 was 51.7% (95% CI 34.7-68.2). The total prevalence of comorbidities in seven studies was 18.4% (95% CI 15.5-21.7). The most prevalent symptoms were fever 27.5% (95% CI 17.6-40.3) and cough 26.1% (95% CI 18.1-36). The prevalence of hospitalisation was 15.1% (95% CI 5.6-35) in 13 studies and of death was 1.5% (95% CI 0.5-3.9) in 12 studies. Comparisons of HCW with and without infection showed an increased relative risk for COVID-19 related to personal protective equipment, workplace setting, profession, exposure, contacts, and testing.
CONCLUSION
CONCLUSIONS
A significant number of HCW were reported to be infected with COVID-19 during the first 6 months of the COVID-19 pandemic, with a prevalence of hospitalisation of 15.1% and mortality of 1.5%. Further data are needed to track the continued risks in HCW as the pandemic evolves and health systems adapt.
Identifiants
pubmed: 33444754
pii: S1201-9712(21)00023-0
doi: 10.1016/j.ijid.2021.01.013
pmc: PMC7798435
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
335-346Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
J Clin Invest. 2020 Sep 1;130(9):4726-4733
pubmed: 32463802
J Microbiol Immunol Infect. 2021 Feb;54(1):54-60
pubmed: 32359943
JAMA. 2020 May 26;323(20):2087-2089
pubmed: 32301962
Med Lav. 2020 Jun 26;111(3):184-194
pubmed: 32624560
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Int J Infect Dis. 2021 Jan;102:239-241
pubmed: 33130210
Invest Radiol. 2020 Jun;55(6):327-331
pubmed: 32118615
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Clin Infect Dis. 2020 Nov 19;71(16):2109-2113
pubmed: 32409825
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Swiss Med Wkly. 2020 Apr 25;150:w20257
pubmed: 32333603
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
Clin Infect Dis. 2020 Nov 19;71(16):2218-2221
pubmed: 32179890
Indian J Occup Environ Med. 2009 Aug;13(2):77-9
pubmed: 20386623
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
J Community Health. 2020 Aug;45(4):675-683
pubmed: 32440724
J Med Virol. 2020 Jul;92(7):807-813
pubmed: 32222986
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Mil Med Res. 2020 May 11;7(1):24
pubmed: 32393381
SN Compr Clin Med. 2020 Jun 25;:1-8
pubmed: 32838147
Euro Surveill. 2020 Mar;25(12):
pubmed: 32234115
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
PLoS One. 2018 Nov 15;13(11):e0206831
pubmed: 30439974
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
Curr Med Sci. 2020 Apr;40(2):295-300
pubmed: 32232652
J Infect Public Health. 2020 Jun;13(6):843-848
pubmed: 32493671
Int J Environ Res Public Health. 2020 Jun 16;17(12):
pubmed: 32560180
J Bone Joint Surg Am. 2020 May 20;102(10):847-854
pubmed: 32271208
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Res Social Adm Pharm. 2021 Jan;17(1):1882-1887
pubmed: 32499159
J Med Virol. 2020 Jun;92(6):612-617
pubmed: 32108351
N Engl J Med. 2020 Jun 4;382(23):2267-2268
pubmed: 32294342
J Infect Public Health. 2020 Mar;13(3):418-422
pubmed: 31056437
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):472-476
pubmed: 32298249
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Clin Infect Dis. 2021 Jan 27;72(2):265-270
pubmed: 33501962
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183934
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347200